The role of lead and cadmium in psychiatry

North American Journal of Medical Sciences

Volumn 6, Issue 8, 2014, Pages 370-376

  Orisakwe, Orish Ebere ^a  

^a Department of Pharmacology   (Nigeria)

Author keywords

Cadmium; Environmental health; Lead; Psychiatry

Indexed keywords

EID: 84906499272     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.139283     Document Type: Review

References (60)

1. Weiss B, Cory-Slechta D, Gilbert SG, Mergler D, Miller E, Miller C, et al. The new tapestry of risk assessment. Neurotoxicology 2008;29:883-90.
2. Freeman H. Mental health and the environment, 1st ed. London: Churchill Livingstone, 1984.
3. Dohrenwend BP, Dohrenwend BS. Psychiatric disorders in urban settings. In: Caplan G, editor. American Handbook of Psychiatry. New York: Basic Books; 1974. p. 424-47.
4. Mueller DP. The current status of urban-rural differences in psychiatric disorder: An emerging trend for depression. J Nerv Ment Dis 1981;169:18-27.
5. Marsella AJ. Urbanization, mental health, and social deviancy. A review of issues and research. Am Psychol 1998;53:624-34.
6. Neff JA. Urbanicity and depression reconsidered. The evidence regarding depressive symptomatology. J Nerv Ment Dis 1983;171:546-52.
7. Verheij RA. Explaining urban-rural variations in health: A review of interactions between individual and environment. Soc Sci Med 1996;42:923-35.
8. Webb SD. Rural-urban differences in mental health. In: Freeman H, editor. Mental health and the environment. London: Churchill Livingstone; 1984. p. 227-49.
9. Peen J, Schoevers RA, Beekman AT, Dekker J. The current status of urban-rural differences in psychiatric disorders. Acta Psychiat Scand 2010;121:84-93.
10. Dekker J, Peen J, Koelen J, Smit F, Schoevers R. Psychiatric disorders and urbanization in Germany BMC Public Health 2008;8:17.
11. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Arch Gen Psychiatry 2001;58:663-8.
12. Pruss-Ustun A, Fewtrell L, Landrigan PJ, Ayuso-Mateos JL. Lead Exposure. In: Ezzati M, AD. Lopez AD, Rodgers A, Murray CJ, editors. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva: World Health Organization; 2004. p. 1495-552.
13. Stanley PC, Wakwe VC. Toxic trace metals in the mentally ill patients. Niger Postgrad Med J 2002;9:199-204.
14. Karim P, Hossain MI, Nazmus Sadat AF, Nahar Z, Md Khalid Hossain MK, Hasnat A. Serum levels of cadmium, calcium, lead and iron in schizophrenic patients. Dhaka Univ J Pharm Sci 2006;5:9-13.
15. Arinola G, Idonije B, Akinlade K, Ihenyen O. Essential trace metals and heavy metals in newly diagnosed schizophrenic patients and those on anti-psychotic medication. J Res Med Sci 2010;15:245-9.
16. Baker EL, Feldman RG, White RF, Harley JP. The role of occupational lead exposure in the genesis of psychiatric and behavioral disturbances. Acta Psychiatr Scand Suppl 1983;303:38-48.
17. Maizlish NA, Parra G, Feo O. Neurobehavioural evaluation of Venezuelan workers exposed to inorganic lead. Occup Environ Med 1995;52:408-14.
18. Rhodes D, Spiro A 3rd, Aro A, Hu H. Relationship of bone and blood lead levels to psychiatric symptoms: The normative aging study. J Occup Environ Med 2003;45:1144-51.
19. Schwartz BS, Lee BK, Bandeen-Roche K, Stewart W, Bolla K, Links J, et al. Occupational lead exposure and longitudinal decline in neurobehavioral test scores. Epidemiology 2005;16:106-13.
20. Opler MG, Buka SL, Groeger J, McKeague I, Wei C, Factor-Litvak P, et al. Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: Further evidence. Environ Health Perspect 2008;116:1586-90.
21. Bouchard MF, Bellinger DC, Weuve J, Matthews-Bellinger J, Gilman SE, Wright RO, et al. Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry 2009;66:1313-9.
22. González-Estecha M, Trasobares EM, Tajima K, Cano S, Fernández C, López JL, et al. Trace elements in bipolar disorder. J Trace Elem Med Biol 2011;25 Suppl 1:S78-83.
23. Eum KD, Korrick SA, Weuve J, Okereke O, Kubzansky LD, Hu H, et al. Relation of cumulative low-level lead exposure to depressive and phobic anxiety symptom scores in middle-age and elderly women. Environ Health Perspect 2012;120:817-23.
24. McFarlane AC, Searle AK, Van Hooff M, Baghurst PA, Sawyer MG, Galletly C, et al. Prospective associations between childhood low-level lead exposure and adult mental health problems: The port pirie cohort study. Neurotoxicology 2013;39:11-7.
25. Hänninen H, Aitio A, Kovala T, Luukkonen R, Matikainen E, Mannelin T, et al. Occupational exposure to lead and neuropsychological dysfunction. Occup Environ Med 1998;55:202-9.
26. Hanninen H, Mantere P, Hernberg S, Seppalainen AM, Kock B. Subjective symptoms in low-level exposure to lead. Neurotoxicology 1979;1:333-47.
27. Susser ES, Brown AS, Gorman JM. Prenatal Exposures in Schizophrenia. Washington: American Psychiatric Press; 1999. pp. 89-112.
28. World Health Organization. The World Health Report 2001. Mental Health: New Understanding, New Hope. Geneva.
29. Arena JM, Drew RN. Poisoning. 1995. Toxicology-Symptoms- Treatment, Fifth Edition. Charles C. Thomas-Publisher, Springfield Il, 1986; & Merritt's Textbook of Neurology. 9th Ed., Williams and Wilkins, Baltimore & Clinical Management of Poisoning, 3rd Ed. 1995. pp. 753.
30. van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, et al. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry 2009;66:142-51.
31. Shaw W. The unique vulnerability of the human brain to toxic chemical exposure and the importance of toxic chemical evaluation and treatment in orthomolecular psychiatry. J Orthomol Med 2010;25:125-34.
32. Shih RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: A review of studies that measured both blood lead and bone lead. Environ Health Perspect 2007;115:483-92.
33. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model ofschizophrenia: Update 2005. Mol Psychiatry 2005;10:434-49.
34. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry 2012;17:1228-38.
35. Andreazza AC, Kauer-Sant'Anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, et al. Oxidative stress markers in bipolar disorder: A meta-analysis. J Affect Disord 2008;111:135-44.
36. Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 2008;295:H454-65.
37. Hsu PC, Guo YL. Antioxidant nutrients and lead toxicity. Toxicology 2002;180:33-44.
38. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000;29:927-45.
39. Schafer JH, Glass TA, Bressler J, Todd AC, Schwartz BS. Blood lead is a predictor of homocysteine levels in a population-based study of older adults. Environ Health Perspect 2005;113:31-5.
40. Guallar E, Silbergeld EK, Navas-Acien A, Malhotra S, Astor BC, Sharrett AR, et al. Confounding of the relation between homocysteine and peripheral arterial disease by lead, cadmium and renal function. Am J Epidemiol 2006;163:700-8.
41. Fattal O, Budur K, Vaughan AJ, Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006;47:1-7.
42. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, et al. Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006;79:586-92.
43. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007;22:67-73.
44. Jou SH, Chiu NY, Liu CS. Mitochondrial dysfunction and psychiatric disorders. Chang Gung Med J 2009;32:370-9.
45. Peters JL, Kubzansky LD, Ikeda A, Spiro A 3rd, Wright RO, Weisskopf MG, et al. Childhood and adult socioeconomic position, cumulative lead levels, and pessimism in later life: The VA Normative Aging Study. Am J Epidemiol 2011;174:1345-53.
46. Rajan P, Kelsey KT, Schwartz JD, Bellinger DC, Weuve J, Sparrow D, et al. Lead burden and psychiatric symptoms and the modifying infl uence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: The VA Normative Aging Study. Am J Epidemiol 2007;166:1400-8.
47. Lidsky TI, Schneider JS. Lead neurotoxicity in children: Basic mechanisms and clinical correlates. Brain 2003;126:5-19.
48. Virgolini MB, Chen K, Weston DD, Bauter MR, Cory- Slechta DA. Interactions of chronic lead exposure and intermittent stress: Consequencesfor brain catecholamine systems and associated behaviours and HPA axis function. Toxicol Sci 2005;87:469-82.
49. Cory-Slechta DA, Garcia-Osuna M, Greenamyre JT. Lead induced changes in NMDA receptor complex binding: Correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration. Behav Brain Res 1997;85:161-74.
50. Wright RO, Tsaih SW, Schwartz J, Spiro A 3rd, McDonald K, Weiss ST, et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003;14:713-8.
51. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A 3rd, Sparrow D, et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 2007;18:59-66.
52. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res 1999;24:595-600.
53. Cory-Slechta DA, Virgolini MB, Rossi-George A, Thiruchelvam M, Lisek R, Weston D. Lifetime consequences of combined maternal lead and stress. Basic Clin Pharmacol Toxicol 2008;102:218-27.
54. Cory-Slechta DA, Virgolini MB, Thiruchelvam M, Weston DD, Bauter MR. Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect 2004;112:717-30.
55. Rossi-George A, Virgolini MB, Weston D, Cory-Slechta D. A Alterations in glucocorticoid negative feedback following maternal Pb, prenatal stress and the combination: A potential biological unifying mechanism for their corresponding disease profiles. Toxicol Appl Pharmacol 2009;234:117-27.
56. Moore DP, Jefferson JW. Major depressive disorder (DSMIVTR #296.2-296.3) handbook of medical psychiatry. Philadelphia: Mosby Inc; 2004. pp 89-112.
57. Martin-Soelch C. Is depression associated with dysfunction of the central reward system? Biochem Soc Trans 2009;37:313-7.
58. Naranjo CA, Tremblay LK, Busto UE. The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:781-823.
59. Kanofsky JD, Rosen WA, Ryan PB, Decina P, Fieve RR, Kanofsky PB. Lead levels in the hair of bipolar patients and normal controls. Med Hypotheses 1986;20:151-5.
60. Heavy Metal Toxicity 2011, Available from: at http://www. lef.org/ [Last accessed on 2013 Jul 14].